GSK plc (OTC Pink - Current Information:GLAXF)
| 17.56 Delayed Data As of Oct 02 |  -0.46 / -2.55%Today’s Change | 14.34 Today|||52-Week Range 19.60 | +0.43% Year-to-Date |
Latest GLAXF News | Press Releases
| Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report? 12:10pm / Zacks.com - Paid Partner Content | GSK (GSK) Stock Moves -1.14%: What You Should Know Sep 26 / Zacks.com - Paid Partner Content |
| AstraZeneca (AZN) Settles Heartburn Drugs Lawsuits for $425M 8:17am / Zacks.com - Paid Partner Content | GSK (GSK) Outpaces Stock Market Gains: What You Should Know Sep 25 / Zacks.com - Paid Partner Content |
| GSK (GSK) Stock Moves -0.55%: What You Should Know Oct 03 / Zacks.com - Paid Partner Content | CDC Recommends Pfizer's (PFE) RSV Jab to Protect Newborns Sep 25 / Zacks.com - Paid Partner Content |
| GSK (GSK) Stock Sinks As Market Gains: What You Should Know Oct 02 / Zacks.com - Paid Partner Content | Biotech Stock Roundup: GSK's Drug Approval, MRNA's Vaccine News, PTCT & SPRY Down Sep 21 / Zacks.com - Paid Partner Content |
| Moderna's Shares Could Take Off if These 2 Things Happen Sep 30 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 18.02 |
| Today’s open | 17.56 |
| Day’s range | 17.56 - 17.56 |
| Volume | 404 |
| Average volume (3 months) | 2,944 |
| Market cap | $73.8B |
Data as of 10/02/2023
Growth & Valuation
| Earnings growth (last year) | +203.68% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -23.01% |
| P/E ratio | -- |
| Price/Sales | 1.96 |
| Price/Book | 5.70 |
Competitors
Data as of 4:00pm ET, 10/04/2023
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $36.1B |
| Annual profit (last year) | $18.4B |
| Net profit margin | 15.21% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Middlesex, Greater London |
Forecasts
Chart unavailable
